If you liked this article you might like

The Pain Before the Gains: Cramer's 'Mad Money' Recap (Thursday 1/19/17)
Why Bristol-Myers Squibb May Be a Merger Target Soon
Amazon, Merck, Freshpet: Jim Cramer's Views
Allergan, Schlumberger, IBM: Doug Kass' Views